Medicare Enrolled
Dr. Carlos Buznego, M.D.
Ophthalmology · Miami, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Buznego from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Buznego?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Buznego
Dr. Carlos Buznego is an ophthalmology specialist in Miami, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Buznego performed 1,525 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Buznego received a total of $285,148 from 62 pharmaceutical and/or device companies across 983 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Buznego is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ 1,525 Medicare services
$285,148 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 58902 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗1,525
Medicare services
Bottom 37% in FL for ophthalmology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$100
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
368 | $99 | $199 |
| Visual field test, extended A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam. |
240 | $48 | $102 |
| Optic nerve imaging (OCT scan) Imaging of the optic nerve. |
220 | $26 | $100 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
156 | $70 | $148 |
| Corneal topography and eye depth measurement This procedure measures the curvature and depth of the cornea, the clear front surface of the eye. |
123 | $31 | $109 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
117 | $116 | $250 |
| Cataract surgery with lens implant Surgical removal of the clouded natural lens of the eye and replacement with an artificial prosthetic lens to restore vision. |
91 | $446 | $2,100 |
| Laser removal of recurring cataract A laser procedure to remove a recurring cataract within the lens capsule. |
63 | $276 | $406 |
| Laser repair to improve eye fluid flow A laser procedure used to enhance the drainage of fluid within the eye. |
51 | $198 | $666 |
| Comprehensive eye exam, established patient A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider. |
36 | $28 | $175 |
| Ultrasound scan of cornea to determine thickness An ultrasound procedure used to measure the thickness of the cornea. |
21 | $10 | $33 |
| Eye exam, established patient, focused A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom. |
14 | $19 | $119 |
| Eye drainage system examination An examination of the internal drainage system of the eye to assess how fluid flows and drains from the eye. |
13 | $21 | $47 |
| Retinal imaging (OCT scan) This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye. |
12 | $33 | $100 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
6.0% high complexity
16.6% medium
77.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$285,148
Total received (2018-2024)
Avg $40,735/year across 7 years
Top 3% in FL for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
62
Companies
983
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$31,297
2023
$18,057
2022
$27,583
2021
$47,715
2020
$27,450
2019
$87,113
2018
$45,933
Payments by company (2024)
Glaukos Corporation
$18,063
Sight Sciences, Inc.
$7,122
ABBVIE INC.
$1,056
Bausch & Lomb Americas Inc.
$976
Alcon Vision LLC
$675
SUN PHARMACEUTICAL INDUSTRIES INC.
$445
NEW WORLD MEDICAL,INC.
$416
Tarsus Pharmaceuticals, Inc.
$365
Harrow Eye, LLC
$299
Dompe US, Inc.
$267
Oyster Point Pharma, Inc.
$240
LENSAR, Inc.
$235
Amgen Inc.
$154
Regeneron Healthcare Solutions, Inc.
$151
Mallinckrodt Hospital Products Inc.
$151
Astellas Pharma US Inc
$143
BIOTISSUE HOLDINGS INC.
$132
Apellis Pharmaceuticals, Inc.
$123
ANI Pharmaceuticals, Inc.
$70
Thea Pharma Inc.
$58
Rayner Intraocular Lenses Limited
$47
Halozyme Inc
$46
Johnson & Johnson Surgical Vision, Inc.
$34
Genentech USA, Inc.
$30
Top 3 companies account for 83.8% of 2024 payments
All-time payments by company (2018-2024) ›
Glaukos Corporation
$71,847
Kala Pharmaceuticals, Inc.
$63,711
Sun Pharmaceutical Industries Inc.
$30,656
LENSAR, Inc.
$23,704
GLAUKOS CORPORATION
$18,508
Aerie Pharmaceuticals, Inc.
$18,021
Sight Sciences, Inc.
$14,384
Allergan Inc.
$5,249
Johnson & Johnson Surgical Vision, Inc.
$4,429
NEW WORLD MEDICAL,INC.
$3,471
Bausch & Lomb Americas Inc.
$3,158
Alcon Vision LLC
$2,766
ABBVIE INC.
$2,733
Horizon Therapeutics plc
$2,526
Bausch & Lomb, a division of Bausch Health US, LLC
$2,412
Allergan, Inc.
$1,989
Eyevance Pharmaceuticals LLC
$1,943
Alcon Research LLC
$1,750
Harrow Eye, LLC
$1,699
AbbVie Inc.
$1,455
Dompe US, Inc.
$904
SUN PHARMACEUTICAL INDUSTRIES INC.
$785
Oyster Point Pharma, Inc.
$694
Mallinckrodt Hospital Products Inc.
$658
Alcon Laboratories Inc
$630
Novartis Pharmaceuticals Corporation
$591
Regeneron Healthcare Solutions, Inc.
$587
Carl Zeiss Meditec, Inc.
$543
Tarsus Pharmaceuticals, Inc.
$365
Thea Pharma Inc.
$318
Rayner Intraocular Lenses Limited
$253
Apellis Pharmaceuticals, Inc.
$218
Shire North American Group Inc
$200
Carl Zeiss Meditec USA, Inc.
$184
Omeros Corporation
$175
Amgen Inc.
$154
Astellas Pharma US Inc
$143
BIOTISSUE HOLDINGS INC.
$132
Mallinckrodt Enterprises LLC
$113
Ivantis, Inc
$113
TISSUETECH, INC.
$87
Genentech USA, Inc.
$75
BioTissue Holdings, Inc.
$72
ANI Pharmaceuticals, Inc.
$70
BIOTISSUE HOLDINGS, INC.
$70
Ocular Therapeutix, Inc.
$65
NovaBay Pharmaceuticals, Inc.
$62
Merz Pharmaceuticals, LLC
$60
Beaver-Visitec International, Inc.
$48
TissueTech, Inc.
$47
Halozyme Inc
$46
Coherus Biosciences Inc.
$44
EyePoint Pharmaceuticals US, Inc.
$33
Immunocore Limited
$30
Dutch Ophthalmic, USA
$26
RxSight Inc
$25
EYEVANCE PHARMACEUTICALS LLC
$24
Merz North America, Inc.
$20
Akorn, Inc.
$19
Carl Zeiss Meditec AG
$19
Iridex Corporation
$18
Quidel Corporation
$14
Top 3 companies account for 58.3% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVEFOCUS · ALPHAGAN P · ARGOS · ARTEVO 800 · AcrySof · AcrySof IQ PanOptix · AcrySof IQ PanOptix UV IOL · AcrySof IQ VIVITY IOL · Ahmed Glaucoma Valve · Avenova · BEPREVE · BOTOX · BOTOX COSMETIC · BROMSITE · BromSite (bromfenac ophthalmic solution) 0.075% · CE-marked KXLA system · CEQUA · CEQUA (cyclosporine ophthalmic solution) 0.09% · COMBIGAN · CT Lucia · Centurion · Cequa · Cimerli · Clareon · DEXYCU · DOCTORS ALLERGY FORMULA · DURYSTA · EVA · EYLEA · EYLEA HD · EYSUVIS · Flarex · HYDRUS Microstent · HYLENEX RECOMBINANT · Hydrus · IACCESS · IHEEZO · INVELTYS · IOLMaster 500 · ISTENT INJECT W · ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM · IYUZEH · InflammaDry · Izervay · KIMMTRAK · Kahook Dual Blade · LENSAR LASER SYSTEM · LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) · LOTEMAX SM · LUMIGAN · MIEBO · None Specified · OMIDRIA · OMNI · OMNI SURGICAL SYSTEM · OMNI(R) SURGICAL SYSTEM (US) · OPMI Lumera · ORA · OXERVATE · OZURDEX · Omidria · Oxervate · PROKERA · PROLENSA · PURIFIED CORTROPHIN GEL · PanOptix · Prokera · QUATERA 700 · QULIPTA · RESTASIS · RESTASIS MULTIDOSE · RayOne EMV · ReSure Sealant · Rhopressa · STELLARIS · SURGICAL MISC · Simbrinza · Syfovre · TEPEZZA · TRAVATAN Z · TYRVAYA · Tecnis 1-piece IOL · Tecnis IOL · Tecnis Multifocal Family of 1-piece IOLS · Tecnis Symfony IOL · Tobradex ST · UBRELVY · VEVYE · VISUDYNE · VUITY · VYZULTA · Vabysmo · Whitestart Phacoemulsficiation System · XDEMVY · XELPROS · XELPROS (latanoprost ophthalmic emulsion) 0.005% · XEN · XEN GLAUCOMA TREATMENT SYSTEM · XEOMIN · XIIDRA · Xeomin · Zerviate · Zioptan · combined machine · enVista MX60 IOL · iDose · iDose TR · iSTENT iNJECT TRABECULAR MICRO-BYPASS STENT SYSTEM · iStent · iStent Trabecular Micro-Bypass Stent System · iStent Trabecular Micro-Bypass System Model iS3 · iStent infinite Trabecular Micro-Bypass System Model iS3 · iStent inject Trabecular Micro-Bypass Stent System · iStent inject Trabecular Micro-Bypass System Model G2-M-IS · iStent inject W · rhopressa · rocklatan
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Ophthalmologists in nearby ZIP areas
274
County median income
$68,694
Nearest hospital to ZIP centroid (approximate)
BAPTIST HOSPITAL OF MIAMI
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Buznego is a clinical cardiology specialist, with moderate Medicare volume, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Buznego experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Buznego performed 368 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Buznego receive payments from pharmaceutical companies?
Yes. Dr. Buznego received a total of $285,148 from 62 companies across 983 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Buznego's costs compare to other ophthalmologists in Miami?
Dr. Buznego's average Medicare payment per service is $100. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Buznego) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Ophthalmologists in Miami
Browse ophthalmologists in Miami ranked by procedure volume and transparency data.
Highest volume
Top Ophthalmologists in FL
Ophthalmologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Ophthalmologists in FL
Which FL ophthalmologists receive the most from drug and device companies.
By company
Glaukos Corporation Payments to Doctors
See all physicians who received payments from Glaukos Corporation.
By company
Kala Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Kala Pharmaceuticals, Inc.
By company
Sun Pharmaceutical Industries Inc. Payments to Doctors
See all physicians who received payments from Sun Pharmaceutical Industries Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology